Mesoblast Limited (ASX:MSB)
1.855
+0.070 (3.92%)
Oct 27, 2026, 4:10 PM AEDT
Mesoblast Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Mesoblast stock has a consensus rating of "Strong Buy" and an average price target of $3.57. The average 1-year stock price forecast is 92.61% higher than the current stock price, while the lowest is $2.80 (+50.94%) and the highest is $4.40 (+137.20%).
Price Target: $3.57 (+92.61%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mesoblast stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $4.45 → $4.40 | Buy | Maintains | $4.45 → $4.40 | +137.20% | Oct 19, 2026 |
| Jefferies | Jefferies | Buy Maintains $2.90 → $2.80 | Buy | Maintains | $2.90 → $2.80 | +50.94% | Oct 16, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $3.56 | Buy | Maintains | $3.56 | +91.91% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
182.61M
from 120.25M
Increased by 51.86%
Revenue Next Year
298.27M
from 182.61M
Increased by 63.33%
EPS This Year
-0.02
from -0.04
EPS Next Year
0.07
from -0.02
EPS and Forward PE are based on non-GAAP adjusted numbers.